Christopher J. Christie's Insider Trades & SAST Disclosures

Christopher J. Christie's most recent trade in Pacira BioSciences Inc was a trade of 11,279 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pacira BioSciences Inc
Christopher J. Christie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 11,279 11,279 - - Stock Option (Right to Buy)
Pacira BioSciences Inc
Christopher J. Christie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 6,163 16,654 (0%) 0% 0 Common Stock
Pacira BioSciences Inc
Christopher J. Christie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 12,179 12,179 - - Stock Option (Right to Buy)
Pacira BioSciences Inc
Christopher J. Christie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 5,230 10,491 (0%) 0% 0 Common Stock
Pacira BioSciences Inc
Christopher J. Christie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,925 12,925 - - Stock Option (Right to Buy)
Pacira BioSciences Inc
Christopher J. Christie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,775 5,261 (0%) 0% 0 Common Stock
Pacira BioSciences Inc
Christopher J. Christie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 8,225 8,225 - - Stock Option (Right to Buy)
Pacira BioSciences Inc
Christopher J. Christie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 1,160 3,486 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades